Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Epithelial Ovarian Cancer

glucose, (beta-d)-isomer has been researched along with Epithelial Ovarian Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, DW; Huang, JZ; Li, LL; Luo, X; Tan, XY; Wu, ZY1
Jia, L; Jin, H; Lu, Y; Lv, M; Ming, Y; Yu, Y; Zhao, H; Zhao, N; Zheng, Z; Zhou, J1

Other Studies

2 other study(ies) available for glucose, (beta-d)-isomer and Epithelial Ovarian Cancer

ArticleYear
The Effect of Calycosin-7-O-β-D-Glucoside and its Synergistic Augmentation of Cisplatin-induced Apoptosis in SK-OV-3 Cells.
    Current pharmaceutical design, 2022, Volume: 28, Issue:26

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Ovarian Epithelial; Caspase 3; Cell Line, Tumor; Cisplatin; Female; Glucosides; Humans; Isoflavones; Ovarian Neoplasms; Tumor Suppressor Protein p53

2022
Corilagin sensitizes epithelial ovarian cancer to chemotherapy by inhibiting Snail‑glycolysis pathways.
    Oncology reports, 2017, Volume: 38, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glucosides; Glycolysis; Herbal Medicine; Humans; Hyaluronan Receptors; Hydrolyzable Tannins; Neoplasm Proteins; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Proteomics; Signal Transduction; STAT3 Transcription Factor

2017